Results

eNauka >  Rezultati >  Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
Naziv: Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
Autori Neggers, Sebastian JCMM; Pronin, Vyacheslav; Balcere, Inga; Lee, Moon-Kyu; Rozhinskaya, Liudmila; Bronstein, Marcello D; Gadelha, Mônica R; Maisonobe, Pascal; Sert, Caroline; van, der Lely Aart Jan
Godina: 2015
Publikacija: European Journal of Endocrinology
ISSN: 0804-4643 European Journal of Endocrinology Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 173 br. 3 str. 313-323
DOI: 10.1530/eje-15-0215
WoS-ID: 000359263200010
Scopus-ID: 2-s2.0-84940660664
PMID: 26047625
PMCID: PMC4544680
URI: https://enauka.gov.rs/handle/123456789/341392
Izvor metapodataka: Migrirano iz RIS podataka
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

46
SCOPUSTM
17
PubMed CentralTM
31
OpenCitations
38
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.